RxSight, Inc. increased earnings guidance for the full year 2024. For the year, the company expected revenue of $132.0 million to $137.0 million, representing implied growth of 48% to 54% compared to 2023, up from prior guidance of $128.0 million to $135.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.96 USD | -0.31% | -2.25% | +51.19% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.19% | 2.38B | |
-7.38% | 177B | |
-0.46% | 108B | |
-6.98% | 65.55B | |
+2.65% | 50.66B | |
+5.27% | 42.58B | |
+6.44% | 40.74B | |
+19.92% | 31.07B | |
+16.16% | 25.45B | |
-7.00% | 23.85B |
- Stock Market
- Equities
- RXST Stock
- News RxSight, Inc.
- RxSight, Inc. Increases Earnings Guidance for the Full Year 2024